The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Anti-Rabies Serum Market Projected To Become By 2030 Based On Its 2026 Valuation?
The anti-rabies serum market has demonstrated significant growth in recent years. It is projected to increase from $1.5 billion in 2025 to $1.58 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.6%. This historical growth can be attributed to several factors, including the rising incidence of rabies exposure cases, the broadening of hospital-based emergency treatment protocols, the availability of equine-derived immunoglobulins, government-backed rabies control programs, and enhanced awareness of post-exposure prophylaxis.
The anti-rabies serum market is projected to experience robust expansion over the coming years. Its value is anticipated to reach $1.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.3%. This projected increase is driven by factors such as the greater acceptance of human anti-rabies immunoglobulin, the expansion of rabies prevention programs in developing areas, increased spending on biologics production, a heightened emphasis on safer serum options, and the reinforcement of public health vaccination systems. Key trends anticipated during this period encompass a rise in the use of human-derived immunoglobulins, a growing demand for prefilled syringe designs, the broadening of cold-chain optimized serum delivery networks, an increased focus on developing high-purity antibody formulations, and enhanced standardization for post-exposure prophylaxis procedures.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Anti-Rabies Serum Market?
The escalating occurrence of dog bites is anticipated to stimulate the expansion of the anti-rabies serum market in the future. Dog bites encompass injuries, ranging from minor to severe, inflicted when a dog scratches or bites an individual. These injuries can result in infections, serious wounds, and, in some instances, the transmission of diseases like rabies. Effective prevention and prompt medical attention are essential for managing and mitigating the risks associated with dog bites. Several factors contribute to the increasing prevalence of dog bites, such as greater urbanization leading to more frequent interactions between humans and dogs, a higher number of unrestrained or poorly trained dogs, and insufficient public awareness or education regarding dog behavior and bite prevention. This rise in dog bite incidents has consequently fueled demand for anti-rabies serum, as its timely administration is critical for preventing rabies in individuals exposed to potentially infected animals. For instance, in 2023, according to the American Veterinary Medical Association, a US-based non-profit organization, the average cost for dog bite insurance claims was $58,545. Insurers paid out $1.12B in liability claims related to dog bites and other dog-related injuries in 2023, with dog bite claims increasing by nearly 10% in 2023. Ultimately, the growing prevalence of dog bites is a key driver for the anti-rabies serum market’s growth.
What Segment Groups Are Identified Within The Anti-Rabies Serum Market?
The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals
Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
What Trends Are Advancing Progress In The Anti-Rabies Serum Market?
Leading companies within the anti-rabies serum market are engaging in strategic collaborations to bolster product innovation and extend their market reach. These strategic collaborations represent a process where organizations combine their respective strengths and assets to achieve mutual benefits and success. An illustrative instance occurred in July 2023 when Kedrion S.p.A., a US-based biopharmaceutical firm, partnered with Kamada, an Israel-based biopharmaceutical firm, for the distribution of KEDRAB (Rabies Immune Globulin [Human]) within the US. This joint venture has been pivotal in the co-development and licensing of the product in the U.S., concurrently with efforts to enhance disease awareness. Through their collective endeavors, the partnership has been effective in shielding individuals exposed to bites from rabid animals against serious and potentially life-threatening health conditions.
Which Companies Hold Significant Positions In The Anti-Rabies Serum Market?
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals
Read the full anti-rabies serum market report here:
https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report
Which Regions Are Projected To Dominate The Anti-Rabies Serum Market In The Coming Years?
North America was the largest region in the anti-rabies serum market in 2025. The regions covered in the anti-rabies serum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Anti-Rabies Serum Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20468&type=smp
Browse Through More Reports Similar to the Global Anti-Rabies Serum Market 2026, By The Business Research Company
Rabies Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report
Animal Therapeutics And Diagnostics Market Report 2026
Anti Inflammatory Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model